Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients
Predicting Early Treatment Termination (Dropout) and Post-treatment Clinical Outcome From Neuropsychological Functions in Abstinent Substance Use Dependent (SUD) Patients
Sponsor: Oslo University Hospital
Listed as NCT03220373, this observational or N/A phase trial focuses on Substance Use Disorder (SUD) and remains ongoing. Sponsored by Oslo University Hospital, it has been updated 8 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
Jan 2021 — Feb 2024 [monthly]
Active Not Recruiting
-
May 2020 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Jun 2018 — May 2020 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oslo University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .